From Models to Heartbeats: Computational Design of Vagus Nerve Stimulation for Cardiac Health
This webinar explores closed-loop cardiac rhythm control restoration in heart-transplant patients from model development to in silico regulatory evidence for safety and efficacy trials.
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.
Economic Impact of Representativeness in Clinical Trials: How Real-World Data Can Help
This panel of real-world evidence (RWE) experts explore the economic impact and role of RWE in improving representativeness of research.
Syapse Real-World Dialogue: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology
Join Drs. Nitin Baliga and Thomas Brown for an in-depth discussion on utilizing real-world data, machine learning, and systems biology for benefiting therapeutic development.
Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
Join Renee Willmon, MSc as she demonstrates Health Storylines as a disease-agnostic and customizable platform that connects healthcare stakeholders to engaged patients.
#ExpertAnswers: Anuj Kalsy and Robert Snyder On The Variant-Rich Biobank
Anuj Kalsy and Robert Snyder showcase Precision for Medicine's variant-rich biobank, including discussion on biospecimen types, applications, screening methods, and support for companion diagnostic development.
Data Integrity in Decentralized Clinical Trials (DCTs)
Experts expand on the need for a comprehensive understanding of all sources of data in DCTs, and the need to evaluate those data centrally in real time to mitigate the risks associated with their capture (including data capture at the edge of the network (wearables)).
The Variant-Rich Biobank: An Insider’s Look
Experts provide a showcase of Precision for Medicine's variant-rich biobank. including discussion on biospecimen types, applications, screening methods, and support for companion diagnostic development.
Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible
Matthias Hunger, Céline Taveau, and Ankit Pahwa present the challenges and opportunities when using external control arm studies in submissions to HTA agencies.
Overcoming Clinical Research Challenges: Analyzing EHR Data to Replicate Clinical Trials and Construct External Control Arms
Mac Bonafede, Stella Chang, and Dr. Rajesh Dash provide an overview on defeating common clinical trial barriers by combining EHR data with advanced analytics technologies.